In the 20th Century, Hemodialysis for Kidney Patients has to be one of the biggest breakthroughs in medicine. However, some healthcare professionals are questioning the effectiveness of that treatment because of inadequate outcomes, including a persistently high death rate, derived from being dialyzed 3to4.5 hours per session, three times a week.
For the past 30 years, KT/V has been accepted as the primary standard for measuring the adequacy of dialysis a CKD Patient was receiving. However, there are other important markers which determine adequate dialysis as well, such as fluid, phosphate balance, and middle molecule removal (molecules not small enough to be dialyzed off). Consequently, Hemodialysis is limited in its scope to effectively treat all of these markers. Therefore, Researchers are actively testing new strategies to attempt to improve CKD Patient outcomes for dialysis.
Two of these strategies which were closely considered, Short and Long Nocturnal Daily Dialysis, reflected the difficulty in recruiting patients for them. Researchers reported a higher rate in blood access-related complications, a higher financial burden, and logistical difficulties. However, this prescription has been associated with excellent performance results which may overcome its limitations, and a potential to improve conventional Hemodialysis outcomes.
Even though the research is continuing, it is highly recommended that these alternative strategies be discussed with your health care team, and be consider as an option for inclusion in your treatment plan.